ΠΠΈΡΠ΅ΡΠ°ΡΡΡΠ°.
Π‘ΠΎΠ²ΡΠ΅ΠΌΠ΅Π½Π½ΡΠ΅ ΡΠ΅Ρ
Π½ΠΈΡΠ΅ΡΠΊΠΈΠ΅ Π΄ΠΎΡΡΠΈΠΆΠ΅Π½ΠΈΡ ΠΈΠ½ΡΡΠ»ΠΈΠ½ΠΎΡΠ΅ΡΠ°ΠΏΠΈΠΈ ΡΠ°Ρ
Π°ΡΠ½ΠΎΠ³ΠΎ Π΄ΠΈΠ°Π±Π΅ΡΠ° Ρ Π΄Π΅ΡΠ΅ΠΉ
Danne T, Mortensen HB, Hougaard P et al. For the Hvidore study group on childhood diabetes Persistent differences among centers over 3 years in glycemic control and hypoglycemia in a study of 3,805 children and adolescents with type 1 diabetes from the Hvidore study group. Diabetes Care. 2001; 24: 1342β1347. Weinzimer SA, Ternand C, Howard Π‘ et al, A randomized trial comparing continuous… Π§ΠΈΡΠ°ΡΡ Π΅ΡΡ >
ΠΠΈΡΠ΅ΡΠ°ΡΡΡΠ°. Π‘ΠΎΠ²ΡΠ΅ΠΌΠ΅Π½Π½ΡΠ΅ ΡΠ΅Ρ Π½ΠΈΡΠ΅ΡΠΊΠΈΠ΅ Π΄ΠΎΡΡΠΈΠΆΠ΅Π½ΠΈΡ ΠΈΠ½ΡΡΠ»ΠΈΠ½ΠΎΡΠ΅ΡΠ°ΠΏΠΈΠΈ ΡΠ°Ρ Π°ΡΠ½ΠΎΠ³ΠΎ Π΄ΠΈΠ°Π±Π΅ΡΠ° Ρ Π΄Π΅ΡΠ΅ΠΉ (ΡΠ΅ΡΠ΅ΡΠ°Ρ, ΠΊΡΡΡΠΎΠ²Π°Ρ, Π΄ΠΈΠΏΠ»ΠΎΠΌ, ΠΊΠΎΠ½ΡΡΠΎΠ»ΡΠ½Π°Ρ)
1. King H, Aubert R, Herman W. Global Burden of Diabetes, 1995;2025 Prevalence, numerical estimates, and projections. Diabetes Care. 1998; 21 (9): 1414−1431.
2. Dejkhamron P, Menon R, Sperling M. Childhood diabetes mellitus: Recent advances & future prospects. Indian J. Med. Res. 2007; 125: 231−250.
3. Wild S et al. Global Prevalence of Diabetes, estimates for the year 2000 and projections for 2030. Diabetes Care. 2004; 27 (5): 1047−1053.
4. ΠΡΠ°Π²ΠΈΡΠ΅Π»ΡΡΡΠ²ΠΎ Π ΠΎΡΡΠΈΠΉΡΠΊΠΎΠΉ Π€Π΅Π΄Π΅ΡΠ°ΡΠΈΠΈ, ΠΠΎΡΡΠ°Π½ΠΎΠ²Π»Π΅Π½ΠΈΠ΅ ΠΎΡ 1 Π΄Π΅ΠΊΠ°Π±ΡΡ 2004 Π³. № 715 ΠΎΠ± ΡΡΠ²Π΅ΡΠΆΠ΄Π΅Π½ΠΈΠΈ ΠΏΠ΅ΡΠ΅ΡΠ½Ρ ΡΠΎΡΠΈΠ°Π»ΡΠ½ΠΎ Π·Π½Π°ΡΠΈΠΌΡΡ Π·Π°Π±ΠΎΠ»Π΅Π²Π°Π½ΠΈΠΉ ΠΈ ΠΏΠ΅ΡΠ΅ΡΠ½Ρ Π·Π°Π±ΠΎΠ»Π΅Π²Π°Π½ΠΈΠΉ, ΠΏΡΠ΅Π΄ΡΡΠ°Π²Π»ΡΡΡΠΈΡ ΠΎΠΏΠ°ΡΠ½ΠΎΡΡΡ Π΄Π»Ρ ΠΎΠΊΡΡΠΆΠ°ΡΡΠΈΡ .
5. Meltzer D, Egleston B, Stoffel D, Dasbach E. Effect of future costs on cost-effectiveness of medical interventions among young adults: the example of intensive therapy for type 1 diabetes mellitus. Med Care. 2000; 38: 679−685.
6. Zuhri-Yafi MI, Brosnan PG, Hardin DS. Treatment of type 2 diabetes mellitus in children and adolescents. J. Pediatr. Endocrinol. Metab. 2002; Suppl 1: 541−546.
7. Mohamadi A, Cooke D. Type 2 diabetes mellitus in children and adolescents. Adolesc. Med. State Art. Rev. 2010; 21 (1): 103−119.
8. Caro JJ, Ward AJ, O’Brien JA. Lifetime costs of complications resulting from type 2 diabetes in the U.S. Diabetes Care. 2002; 25 (3): 476−481.
9. Verrotti A, Chiuri RM, Blasetti A et al. Treatments options for paediatric diabetes. Expert Opin Pharmacother, 2010: 29 [Epub ahead of print].
10. Rosenbloom AL, Joe JR, Young RS, Winter WE. Emerging epidemic of type 2 diabetes in youth. Diabetes Care. 1999; 22 (2): 345−354.
11. Rosenbloom AL. Increasing incidence of type 2 diabetes in children and adolescents: treatment considerations. Paediatr Drugs. 2002; 4 (4): 209−221.
12. Haines L, Wan KC, Lynn R et al. Rising incidence of type 2 diabetes in children in the U.K. Diabetes Care. 2007; 30 (5): 1097−1101.
13. Phillips J, Phillips PJ. Children get type 2 diabetes too. Aust Fam. Physician. 2009; 38 (9): 699−703.
14. Mohamadi A, Cooke DW. Type 2 diabetes mellitus in children and adolescents. Adolesc. Med. State Art. Rev. 2010; 21 (1): 103−119.
15. Rolla Π. The pathophysiological basis for intensive insulin replacement. International Journal of Obesity. 2004; 28 (Suppl 2): S3-S7.
16. Couper J, Prins J. Recent advances in therapy of diabetes. MJA. 2003; 179 (8): 441−447.
17. Ludvigsson J, Haas R. Continuous subcutaneous glucose monitoring improved metabolic control in pediatric patients. Pediatrics. 2003; 111: 933−938.
18. White NH, Cleary PA, Dahms W et al. Beneficial effects of intensive therapy of diabetes during adolescence: outcomes after conclusion of the Diabetes Control and Complications Trial (DCCT). Diabetes Control and Complications Trial (DCCT)/ Epidemiology of Diabetes Interventions and Complications. J. Pediatr. 2001; 139:1923;1927.
19. Saul N, Maryniuk MD. Using the glycemic index in diabetes management. Am. J. Nurs. 2010; 110 (7): 68−69.
20. Effects of Medical Therapies on Retinopathy Progression in Type 2 Diabetes The ACCORD Study Group and ACCORD Eye Study Group. N. Engl. J. Med. 2010; 363: 233−244.
21. Giugliano D, Ceriello A, Esposito K. Glucose metabolism and hyperglycemia. Am. J. Clin. Nutr. 2008; 87 (1): 217S-222S.
22 .DaileyG. Assessing glycemic control with self-monitoring of blood glucose and hemoglobin A (1c) measurements. Mayo. Clin. Proc. 2007; 82 (2): 229−235.
23. Kadish A A servomechanism for blood sugar control. Biomed. Sci. Instrum. 1963; 1:171−176.
24. Bittar EE. Insulin and the sodium pump of the Maia muscle fibre. Nature. 1967; 214 (5089): 726−727.
25. Wolff-McDonagh P, Kaufmann J, Foreman S et al. Using Insulin Pump Therapy in Poorly Controlled Type 2 Diabetes. Diabetes Educ. 2010; 22 [Epub ahead of print].
26. Kapellen TM, Heidtmann B, Bachmann J et al. Indications for insulin pum p therapy in different age groups-an analysis of 1,567 children and adolescents. Diabet Med. 2007; 24: 836−842.
27. Tamborlane WV, Sherwin RS, Genel M, Felig P. Reduction to normal of plasma glucose in juvenile diabetics by subcutaneous administration of insulin with a portable infusion pump. N. Engl. J. Med. 1979; 300: 573−578.
28. Weinzimer SA, Ternand C, Howard Π‘ et al, A randomized trial comparing continuous subcutaneous insulin infusion of insulin aspart versus insulin lispro in children and adolescents with type 1 diabetes. Diabetes Care. 2008; 31(2): 210−215.
29. Ahern JH, Boland EA, Doane R et al, Insulin pump therapy in pediatrics: a therapeutic alternative to safely lower therapy HbA1c levels across all age groups. Pediatric Diabetes. 2002; 3: 10−15.
30. Wilson DM, Buckingham BA, Kunselman EL et al. A two-center randomized controlled feasibility trial of insulin pump therapy in young children with diabetes. Diabetes Care. 2005; 28: 15−19.
31. Fox LA, Buckloh LM, Smith SD et al. A randomized controlled trial of insulin pump therapy in young children with type 1 diabetes. Diabetes Care. 2005; 28: 1277−1281.
32. Danne T, Mortensen HB, Hougaard P et al. For the Hvidore study group on childhood diabetes Persistent differences among centers over 3 years in glycemic control and hypoglycemia in a study of 3,805 children and adolescents with type 1 diabetes from the Hvidore study group. Diabetes Care. 2001; 24: 1342−1347.
33. ΠΠ΅ΡΠ΅ΡΠΊΠΎΠ²Π° B.A., ΠΡΡΠ°Π΅Π²Π° Π’. Π., ΠΠΌΠ΅Π»ΡΡΠ½ΠΎΠ² A.O. ΠΠΎΠΌΠΏΠΎΠ²Π°Ρ ΠΈΠ½ΡΡΠ»ΠΈΠ½ΠΎΡΠ΅ΡΠ°ΠΏΠΈΡ Π² ΠΏΠ΅Π΄ΠΈΠ°ΡΡΠΈΡΠ΅ΡΠΊΠΎΠΉ ΠΏΡΠ°ΠΊΡΠΈΠΊΠ΅. ΠΠ΅Π΄ΠΈΠ°ΡΡΠΈΡ. 2008; 87 (5): 45−50.
34. Olinder AL, Kernell A, Smide Π. Treatment with CSII in two infants with neonatal diabetes mellitus. Pediatr Diabetes. 2006; 7 (5): 284−288.
35. Weinzimer SA, Swan KL, Sikes KA, Ahern JH. Emerging evidence for the use of insulin pump therapy in infants, toddlers, and preschool-aged children with type 1 diabetes. Pediatr Diabetes. 2006; 7 (Suppl 4): 15−19.
36. Sirotinin SV, George Π‘ J. Computer-Aided Learning in Insulin Pump Training. J. Diabetes Sci. Technol. 2010; 4 (4): 1022−1026.
37. Alsaleh FM, Smith FJ, Ready S, Taylor KM. Insulin pumps: from inception to the present and toward the future. Clin. Pharm. Ther. 2010; 35 (2): 127−138.